Atlas Trials

Exercise as a Supportive Measure for Patients Undergoing Checkpoint-inhibitor Treatment

Clinical trial NCT03171064 · COMPLETED

Trial details

NCT number
NCT03171064
Sponsor
University Hospital Heidelberg
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
PD-1 AntibodiesExerciseMelanoma
Start date
2017-09-05
Primary completion
2022-07-30
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.